Financial results - NEUROGENICA SRL

Financial Summary - Neurogenica Srl
Unique identification code: 36276776
Registration number: J36/320/2016
Nace: 8622
Sales - Ron
35.169
Net Profit - Ron
9.896
Employee
1
The most important financial indicators for the company Neurogenica Srl - Unique Identification Number 36276776: sales in 2023 was 35.169 euro, registering a net profit of 9.896 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Neurogenica Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - 118 898 13.661 19.041 22.976 23.416 30.276 35.169
Total Income - EUR - - 118 898 13.661 19.041 22.976 23.417 30.276 35.172
Total Expenses - EUR - - 479 1.306 9.088 22.161 22.773 21.672 22.872 24.967
Gross Profit/Loss - EUR - - -361 -409 4.573 -3.120 203 1.745 7.403 10.205
Net Profit/Loss - EUR - - -365 -435 4.163 -3.691 -434 1.057 6.513 9.896
Employees - - 0 0 0 0 0 0 0 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 16.5%, from 30.276 euro in the year 2022, to 35.169 euro in 2023. The Net Profit increased by 3.402 euro, from 6.513 euro in 2022, to 9.896 in the last year.

Check the financial reports for the company - Neurogenica Srl

Rating financiar

Financial Rating -
Neurogenica Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Neurogenica Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Neurogenica Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Neurogenica Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Neurogenica Srl - CUI 36276776

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - 0 0 0 22.949 15.760 9.341 2.691 1.143
Current Assets - - 163 45 6.394 10.484 10.903 7.513 13.805 14.732
Inventories - - 0 0 0 0 0 0 0 0
Receivables - - 0 27 1.335 1.368 1.973 1.445 3.046 2.490
Cash - - 163 17 5.059 9.116 8.929 6.068 10.759 12.242
Shareholders Funds - - -320 -750 3.427 -331 -759 315 6.818 13.256
Social Capital - - 45 44 43 42 41 40 41 40
Debts - - 483 795 2.967 33.764 27.421 16.540 9.679 2.618
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 14.732 euro in 2023 which includes Inventories of 0 euro, Receivables of 2.490 euro and cash availability of 12.242 euro.
The company's Equity was valued at 13.256 euro, while total Liabilities amounted to 2.618 euro. Equity increased by 6.459 euro, from 6.818 euro in 2022, to 13.256 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Neurogenica Srl

Comments - Neurogenica Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.